Thank you for subscribing. We will take note of your stated preferences and be in touch accordingly.
Gamifant® (emapalumab-lzsg) is the first FDA-approved treatment specifically developed for primary hemophagocytic lymphohistiocytosis (HLH), targeting interferon gamma (IFNγ) overexpression.1Download Prescribing Information View Product Fact Sheet How to Order Gamifant
Learn more about the role of IFNγ overexpression in HLH and how Gamifant may help.
How to access Gamifant for your patients
Gamifant is supplied in 10 mg/2 mL and 50 mg/10 mL single-use glass vials.
- NDC 72171-501-01 — 10 mg/2 mL (5 mg/mL) single-use vial
- NDC 72171-505-01 — 50 mg/10 mL (5 mg/mL) single-use vial
Gamifant is available for order via our specialty
pharmacy or through one of our two specialty distributors. Please note
that the patient's insurance coverage may dictate how Gamifant should
be ordered. To better understand your patient's benefits please
Sobi Patient Services at 833.597.6530.
McKesson Plasma and Biologics
McKesson Specialty Health
Sign up to stay informed!
Receive updates on Gamifant news and information.
All fields required